doi: 10.3390/jcm13216394 7 MoonJ-YChoiMHKimJ
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from
Evidence and UK Guidance GLP-1 receptor agonists have gained considerable attention for their role in weight management, prompting questions about their effects on abdominal fat
There is no robust body of randomized controlled trial data demonstrating that lipotropic injections cause clinically significant fat loss beyond what the accompanying calorie restriction, activity changes, and clinical monitoring would have produced anyway
The Mounjaro label includes warnings for severe gastrointestinal adverse reactions, acute kidney injury due to volume depletion, acute gallbladder disease, and diabetic retinopathy complications in certain patients
Acute kidney injury secondary to dehydration is a documented serious adverse event with these medications